Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Cadrenal Therapeutics, Inc. (CVKD – Research Report) today and set a price ...
Noble Financial analyst Mark Reichman maintained a Buy rating on Freightcar America (RAIL – Research Report) today and set a price target of ...
Equities research analysts at Noble Financial dropped their Q1 2025 earnings per share estimates for shares of Comstock in a research note issued on Monday, March 10th. Noble Financial analyst M.
Stock analysts at Noble Financial issued their FY2024 earnings per share (EPS) estimates for Gyre Therapeutics in a research report issued to clients and investors on Tuesday, March 11th. Noble ...
Barnes & Noble Education's business is highly seasonal, with the major portion of sales and operating profit realized during ...
Barnes & Noble Education, Inc. announced its financial results for the third quarter of fiscal year 2025, showing a 2.1% increase in revenue to $466.3 million, primarily driven by a 21% year-over ...
Barnes & Noble Education’s business is highly seasonal, with the major portion of sales and operating profit realized during the second and third fiscal quarters. Q3 and YTD FY2025 Financial ...
Christopher Neumann will serve in the same capacity for the Basking Ridge-based company, which is one of the largest ...
Revenue rose 2.1% in the third quarter at B&NE, with the college bookstore turning a net loss last year into a profit in the ...
My parents have spent their careers in noble professions that do not pay well. My dad is a social worker and my mom teaches ...
Noble Corporation plc ("Noble" or the "Company") (NYSE: NE) today announces plans to report financial results for the fourth quarter and full year 2024 on Monday February 17, 2025 after the U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results